A detailed history of Garrison Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Garrison Asset Management, LLC holds 38,490 shares of ABT stock, worth $3.97 Million. This represents 2.33% of its overall portfolio holdings.

Number of Shares
38,490
Previous 38,874 0.99%
Holding current value
$3.97 Million
Previous $4.28 Million 2.22%
% of portfolio
2.33%
Previous 2.36%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $42,055 - $46,448
-384 Reduced 0.99%
38,490 $4.37 Million
Q4 2023

May 24, 2024

SELL
$90.19 - $110.4 $32,378 - $39,633
-359 Reduced 0.92%
38,874 $4.28 Million
Q4 2023

Feb 01, 2024

SELL
$90.19 - $110.4 $32,378 - $39,633
-359 Reduced 0.92%
38,874 $4.28 Million
Q3 2023

May 24, 2024

SELL
$95.53 - $114.62 $3,725 - $4,470
-39 Reduced 0.1%
39,233 $3.8 Million
Q3 2023

Oct 23, 2023

BUY
$95.53 - $114.62 $95 - $114
1 Added 0.0%
39,233 $3.8 Million
Q2 2023

May 24, 2024

BUY
$100.78 - $112.29 $24,287 - $27,061
241 Added 0.62%
39,272 $4.28 Million
Q2 2023

Aug 03, 2023

BUY
$100.78 - $112.29 $20,256 - $22,570
201 Added 0.51%
39,232 $4.34 Million
Q1 2023

May 24, 2024

SELL
$96.86 - $114.01 $32,641 - $38,421
-337 Reduced 0.86%
39,031 $3.95 Million
Q1 2023

Apr 28, 2023

SELL
$96.86 - $114.01 $32,641 - $38,421
-337 Reduced 0.86%
39,031 $3.95 Million
Q4 2022

May 24, 2024

BUY
$95.06 - $111.52 $83,462 - $97,914
878 Added 2.28%
39,368 $4.32 Million
Q4 2022

Feb 07, 2023

SELL
$95.06 - $111.52 $23,860 - $27,991
-251 Reduced 0.63%
39,368 $4.32 Million
Q3 2022

Oct 21, 2022

SELL
$96.76 - $112.03 $26,996 - $31,256
-279 Reduced 0.7%
39,619 $3.83 Million
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $16,841 - $20,356
-165 Reduced 0.41%
39,898 $4.34 Million
Q1 2022

May 09, 2022

SELL
$114.02 - $139.04 $2,394 - $2,919
-21 Reduced 0.05%
40,063 $4.74 Million
Q4 2021

Jan 25, 2022

SELL
$115.53 - $141.46 $17,445 - $21,360
-151 Reduced 0.38%
40,084 $5.64 Million
Q3 2021

Oct 20, 2021

SELL
$116.66 - $129.06 $64,512 - $71,370
-553 Reduced 1.36%
40,235 $4.75 Million
Q2 2021

Jul 21, 2021

SELL
$105.79 - $124.53 $34,910 - $41,094
-330 Reduced 0.8%
40,788 $4.73 Million
Q1 2021

Apr 21, 2021

SELL
$108.84 - $128.23 $116,241 - $136,949
-1,068 Reduced 2.53%
41,118 $4.93 Million
Q4 2020

Feb 02, 2021

SELL
$105.0 - $114.42 $2.93 Million - $3.19 Million
-27,900 Reduced 39.81%
42,186 $4.62 Million
Q3 2020

Oct 28, 2020

SELL
$91.64 - $111.29 $39,680 - $48,188
-433 Reduced 0.61%
70,086 $7.63 Million
Q2 2020

Aug 06, 2020

SELL
$76.57 - $98.0 $122,818 - $157,192
-1,604 Reduced 2.22%
70,519 $6.45 Million
Q1 2020

May 04, 2020

SELL
$62.82 - $91.86 $117,661 - $172,053
-1,873 Reduced 2.53%
72,123 $5.69 Million
Q4 2019

Feb 10, 2020

SELL
$78.51 - $87.4 $135,900 - $151,289
-1,731 Reduced 2.29%
73,996 $6.43 Million
Q3 2019

Nov 08, 2019

SELL
$81.84 - $88.74 $221,868 - $240,574
-2,711 Reduced 3.46%
75,727 $6.34 Million
Q2 2019

Jul 25, 2019

SELL
$72.88 - $85.0 $162,449 - $189,465
-2,229 Reduced 2.76%
78,438 $6.6 Million
Q1 2019

May 06, 2019

SELL
$66.22 - $80.06 $114,494 - $138,423
-1,729 Reduced 2.1%
80,667 $6.45 Million
Q4 2018

Feb 06, 2019

BUY
$65.56 - $74.27 $541,263 - $613,173
8,256 Added 11.14%
82,396 $5.96 Million
Q4 2018

Feb 05, 2019

SELL
$65.56 - $74.27 $734,009 - $831,526
-11,196 Reduced 13.12%
74,140 $3.14 Million
Q3 2018

Nov 02, 2018

SELL
$60.81 - $73.36 $411,136 - $495,986
-6,761 Reduced 7.34%
85,336 $6.26 Million
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $18,998 - $20,968
-330 Reduced 0.36%
92,097 $5.62 Million
Q1 2018

May 07, 2018

SELL
$56.27 - $63.62 $393,271 - $444,640
-6,989 Reduced 7.03%
92,427 $5.54 Million
Q4 2017

Jan 30, 2018

SELL
$53.68 - $57.47 $131,838 - $141,146
-2,456 Reduced 2.41%
99,416 $5.67 Million
Q3 2017

Oct 30, 2017

BUY
$48.06 - $53.64 $4.9 Million - $5.46 Million
101,872
101,872 $5.44 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $181B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Garrison Asset Management, LLC Portfolio

Follow Garrison Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrison Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrison Asset Management, LLC with notifications on news.